Flat interaction-alert lists fire so often that the dangerous warnings get clicked past. A faster, safer habit is mechanistic: identify the main route a drug is cleared by — a CYP enzyme, often CYP3A4, or a transporter — and ask whether the co-prescribed drug inhibits or induces it.
Inhibition raises the substrate's level, often within a day or two; induction lowers it over days to weeks. Opioids such as oxycodone and fentanyl, many statins, and several antifungals and antivirals run through CYP3A4, so adding a strong CYP3A4 inhibitor or inducer alongside them deserves a deliberate dose rethink rather than a dismissed alert.
- Identify the drug's main clearance route — a CYP enzyme or a transporter — before scanning an alert list.
- Inhibition raises drug levels quickly; induction lowers them over days to weeks.
- Treat CYP3A4 substrates (many opioids, statins, antifungals) as high-interaction drugs.
- Act on the mechanistically plausible, serious interactions rather than every low-level alert.
Why it matters
Alert fatigue buries the serious interactions; a mechanistic check keeps attention on the ones that should change a dose.
Read the rest in the app
You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.
Scan to keep reading on your phone. No account needed to start.
Tomorrow morning, before your first patient
One edition a day for clinical pharmacology, written by the desk, every claim tied to its paper. Six minutes.
Get the app — free